KIAA1524 抗体

Li, Zhang, Yang, Wang: "Cancerous inhibitor of protein phosphatase 2A regulates cisplatin resistance in ovarian cancer." in: Oncology letters, Vol. 17, Issue 1, pp. 1211-1216, (2019) (PubMed).

Chen, Tsai, Chao, Wu, Chen, Lin, Liao, Chou, Chiang: "DAPK and CIP2A are involved in GAS6/AXL-mediated Schwann cell proliferation in a rat model of bilateral cavernous nerve injury." in: Oncotarget, Vol. 9, Issue 5, pp. 6402-6415, (2018) (PubMed).

Tian, Chen, Qiao, Zhang, Zheng, Zhao, Chen, Zhang: "CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells." in: Journal of cellular and molecular medicine, Vol. 22, Issue 9, pp. 4150-4160, (2018) (PubMed).

Liu, Hsu, Huang, Lee, Chen, Yang, Jiang, Chen, Lee, Teng: "ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer." in: Molecular oncology, Vol. 12, Issue 10, pp. 1706-1717, (2018) (PubMed).

Wang, Gao, Wang, Liu, Lin, Zhang, Zhao, Zhang, Pan, Sun, Sun, Zhao, Guo, Wang: "Feedback between E2F1 and CIP2A regulated by human papillomavirus E7 in cervical cancer: implications for prognosis." in: American journal of translational research, Vol. 9, Issue 5, pp. 2327-2339, (2017) (PubMed).

Guo, Liu, Su: "CIP2A mediates prostate cancer progression via the c-MYC signaling pathway." in: Tumour biology, Vol. 36, Issue 5, pp. 3583-9, (2015) (PubMed).

Zhang, Chen, Chen, Liu, Wang, Yu, Chen, Zhao: "Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1." in: Oncotarget, Vol. 6, Issue 7, pp. 5253-62, (2015) (PubMed).

Flørenes, Emilsen, Dong, Førsund, Holm, Slipicevic: "Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma." in: Cancer medicine, Vol. 4, Issue 6, pp. 903-13, (2015) (PubMed).

Chen, Yen, Lin, Chen, Yang, Jiang, Lan, Lin, Yu, Hsu, Lin, Teng: "Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy." in: BMC cancer, Vol. 15, pp. 301, (2015) (PubMed).

Khanna, Rane, Kivinummi, Urbanucci, Helenius, Tolonen, Saramäki, Latonen, Manni, Pimanda, Maitland, Westermarck, Visakorpi: "CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations." in: Oncotarget, Vol. 6, Issue 23, pp. 19661-70, (2015) (PubMed).